 Immunome Inc NASDAQ: IMNM shares are trading higher by 19.44 at 3.39 after the company published data demonstrating its COVID-19 antibody cocktail IMM-BCP-01 cleared the omicron variant of SARS-CoV-2 when tested in vivo in hamsters. When tested in hamster models, Immunome says IMM-BCP-01. 